Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (CANVAS‐R): A randomized, placebo‐controlled trial

AIMS: The primary aim of the CANagliflozin cardioVascular Assessment Study‐Renal (CANVAS‐R) is to determine whether the favourable effects of inhibition of the sodium glucose co‐transporter 2 (SGLT2) on blood glucose, blood pressure and body weight are accompanied by protection against adverse renal...

Descripción completa

Detalles Bibliográficos
Autores principales: Neal, Bruce, Perkovic, Vlado, Matthews, David R., Mahaffey, Kenneth W., Fulcher, Greg, Meininger, Gary, Erondu, Ngozi, Desai, Mehul, Shaw, Wayne, Vercruysse, Frank, Yee, Jacqueline, Deng, Hsiaowei, de Zeeuw, Dick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348724/
https://www.ncbi.nlm.nih.gov/pubmed/28120497
http://dx.doi.org/10.1111/dom.12829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348724/
https://www.ncbi.nlm.nih.gov/pubmed/28120497
http://dx.doi.org/10.1111/dom.12829

Ejemplares similares